| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.16 | 0.2 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.24 | 0.2 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.2 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |